(Q53228992)

12 May 2018

title

Improved quality of life in patients with partial seizures after conversion to oxcarbazepine monotherapy. (English)

1 reference

12 May 2018

1 reference

Rajesh C Sachdeo

1

1 reference

12 May 2018

John R Gates

2

1 reference

12 May 2018

Carl W Bazil

3

1 reference

12 May 2018

Gregory L Barkley

4

1 reference

12 May 2018

William Tatum

5

1 reference

12 May 2018

Joseph D'Souza

6

1 reference

12 May 2018

Kevin McCague

7

1 reference

12 May 2018

publication date

24 August 2006

1 reference

12 May 2018

published in

Epilepsy Behavior

1 reference

12 May 2018

volume

9

1 reference

12 May 2018

issue

3

1 reference

12 May 2018

page(s)

457-463

1 reference

12 May 2018

Early identification of refractory epilepsy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

Adolescents with active or inactive epilepsy or asthma: a comparison of quality of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

Development of a novel scale to assess life fulfillment as part of the further refinement of a quality-of-life model for epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

Development of the quality of life in epilepsy inventory.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

Risk factors for poor health-related quality of life in adolescents with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

Commission on Outcome Measurement in Epilepsy, 1994-1997: final report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

Oxcarbazepine: Double-blind, randomized, placebo-control, monotherapy trial for partial seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

Effect of levetiracetam on epilepsy-related quality of life. N132 Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

Changes in quality of life in epilepsy: how large must they be to be real?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

Seizure frequency and the health-related quality of life of adults with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

Seizure reduction and quality of life improvements in people with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

Influence of clinical, demographic, and socioeconomic variables on quality of life in patients with epilepsy: findings from Georgian study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

The effects of adjunctive topiramate therapy on seizure severity and health-related quality of life in patients with refractory epilepsy---a Canadian study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.04.021

10.1016/J.YEBEH.2006.04.021

7 January 2021

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018